Top Banner
25

Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape

Apr 21, 2017

Download

Obaid Ali
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape
Page 2: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape

Welcome in

Pharmaceutical & Biological Regulatory

Sciences

PBRS 2015

Page 3: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape

Overview of Global Regulatory Landscape

Roohi B. Obaid, R. Ph., M. Phil &

Obaid Ali, B. Sc, B. Pharm., M. Phil., Ph. D

A simple outline of

PBRS 2015

Page 4: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape

Opening Message

Whenever the art of medicine is loved, there is also a love of

humanity (Hippocrates)

Page 5: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape

Behind the Regulatory Science

When a patient seeks for treatment of a disease he may experience

an unwanted sometimes horrible potential of risk associated with drugs

or devices or errors etc.

Page 6: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape

Pre-Clinical Studies

Animal Trials

Page 7: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape

Clinical Research

Page 8: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape

Good Laboratory Practice

Page 9: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape

Good Clinical Practice

Page 10: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape

New Drug Application

Page 11: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape

Generic Drug

Page 12: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape

Generic Drug-Labeling

Page 13: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape

Generic Drug-CMC

Page 14: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape

Generic Drug-Biostudies

Page 15: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape

Generic Drugs-Plant Inspection

Page 16: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape

Generic Drugs-Plant Inspection

Stab

ility

Stu

dies

Page 17: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape

Generic Drugs-Plant Inspection

Page 18: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape

Post-marketing Surveillance

Page 19: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape

Biologicals

Page 20: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape

Biologicals

Page 21: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape

Globalization & Harmonization

Page 22: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape

Regulatory World is not complex but very complexRegulations at a high level

Need more detailed interpretation but want flexibility to evolve with science and technology changes

Closing Message

Page 23: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape
Page 24: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape
Page 25: Opening session 21March PBRS 2015 Overview of Global Regulatory Landscape

Questions/ Comments/ [email protected]